Other headlines:FDA clears perfusion software
The newest release of a web-based insurance eligibility verification tool developed by MedCurrent includes capabilities for imaging centers to automate insurance workflow, eliminate errors, reduce denied claims, speed collections, and improve cash flow. MedCurrent Verify connects to databases from more than 350 U.S.-based insurance carriers to secure real-time patient coverage information. Extending this capability to imaging centers will help centers improve claim submission accuracy and optimize reimbursement, according to MedCurrent. This specially developed version of Verify includes specialty templates that deliver radiology-specific eligibility information first, eliminating the need for time-consuming scrolling.
Prism Clinical Imaging has been cleared by the FDA to begin marketing a suite of brain perfusion software programs designed to make functional MRI, diffusion tensor imaging, and advanced physiological studies available in general clinical practice. One module, called Prism Acquire, addresses contrast injection, including preload, and acquisition of time course data on popular MR scanners using gradient-echo and/or spin-echo sequences. The second, Prism Process, provides model-free automatic time course analysis with patented algorithms for leakage correction. The third, Prism View, displays the resulting cerebral blood volume maps integrated with other functional and physiological information and makes them available for export to PACS, treatment planning, and neuronavigation systems.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.